206 related articles for article (PubMed ID: 32883330)
21. G250 Antigen-Targeting Drug-Loaded Nanobubbles Combined with Ultrasound Targeted Nanobubble Destruction: A Potential Novel Treatment for Renal Cell Carcinoma.
Yu Z; Wang Y; Xu D; Zhu L; Hu M; Liu Q; Lan W; Jiang J; Wang L
Int J Nanomedicine; 2020; 15():81-95. PubMed ID: 32021166
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
[TBL] [Abstract][Full Text] [Related]
23. Dual-targeted delivery of paclitaxel and indocyanine green with aptamer-modified ferritin for synergetic chemo-phototherapy.
Yang K; Dong Y; Li X; Wang F; Zhang Y
Colloids Surf B Biointerfaces; 2023 Sep; 229():113437. PubMed ID: 37437411
[TBL] [Abstract][Full Text] [Related]
24. In vivo photoacoustic molecular imaging of breast carcinoma with folate receptor-targeted indocyanine green nanoprobes.
Wang H; Liu C; Gong X; Hu D; Lin R; Sheng Z; Zheng C; Yan M; Chen J; Cai L; Song L
Nanoscale; 2014 Nov; 6(23):14270-9. PubMed ID: 25321626
[TBL] [Abstract][Full Text] [Related]
25. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
26. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
27. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent.
Lozano N; Al-Ahmady ZS; Beziere NS; Ntziachristos V; Kostarelos K
Int J Pharm; 2015 Mar; 482(1-2):2-10. PubMed ID: 25445515
[TBL] [Abstract][Full Text] [Related]
29. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
30. Targeted imaging of orthotopic prostate cancer by using clinical transformable photoacoustic molecular probe.
Qiu C; Bai Y; Yin T; Miao X; Gao R; Zhou H; Ren J; Song L; Liu C; Zheng H; Zheng R
BMC Cancer; 2020 May; 20(1):419. PubMed ID: 32410590
[TBL] [Abstract][Full Text] [Related]
31. LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.
Rakhshan S; Alberti D; Stefania R; Bitonto V; Geninatti Crich S
J Nanobiotechnology; 2021 Jul; 19(1):208. PubMed ID: 34256774
[TBL] [Abstract][Full Text] [Related]
32. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
33. pH- and Ultrasound-Responsive Paclitaxel-Loaded Carboxymethyl Chitosan Nanodroplets for Combined Imaging and Synergistic Chemoradiotherapy.
Shang M; Sun X; Guo L; Shi D; Liang P; Meng D; Zhou X; Liu X; Zhao Y; Li J
Int J Nanomedicine; 2020; 15():537-552. PubMed ID: 32021193
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound-Augmented Phase Transition Nanobubbles for Targeted Treatment of Paclitaxel-Resistant Cancer.
Zhu Y; Zhang G; Li M; Ma L; Huang J; Qiu L
Bioconjug Chem; 2020 Aug; 31(8):2008-2020. PubMed ID: 32628454
[TBL] [Abstract][Full Text] [Related]
35. Photoacoustic ratiometric assessment of mitoxantrone release from theranostic ICG-conjugated mesoporous silica nanoparticles.
Ferrauto G; Carniato F; Di Gregorio E; Botta M; Tei L
Nanoscale; 2019 Oct; 11(39):18031-18036. PubMed ID: 31570915
[TBL] [Abstract][Full Text] [Related]
36. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
Cherukula K; Uthaman S; Park IK
Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
[TBL] [Abstract][Full Text] [Related]
37. Simple structural indocyanine green-loaded microbubbles for dual-modality imaging and multi-synergistic photothermal therapy in prostate cancer.
Yin T; Wang K; Qiu C; Zhang X; Zhou H; You Y; Ren J; Mao R; Yang B; Miao X; Tian J; Zheng R
Nanomedicine; 2020 Aug; 28():102229. PubMed ID: 32502696
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
[TBL] [Abstract][Full Text] [Related]
40. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery.
Xin Y; Liu T; Yang C
Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
